Are Generic Vyvanse Prices Significantly Lower Than Brand?
Yes, generic lisdexamfetamine dimesylate (Vyvanse's active ingredient) costs 70-90% less than the brand-name version. Brand Vyvanse averages $380-$450 for a 30-day supply (30 capsules of 30-70 mg), while generics range from $40-$120 for the same quantity, depending on pharmacy, dosage, and insurance. This gap holds across major U.S. retailers like Walmart, CVS, and GoodRx, where coupons drop generic prices under $50 monthly.[1][2]
How Much Cheaper Are Generics at Specific Pharmacies?
| Pharmacy/Source | Brand (30-day, ~50 mg) | Generic (30-day, ~50 mg) | Savings % |
|-----------------|------------------------|---------------------------|-----------|
| GoodRx | $370-$420 | $35-$70 | 80-90% |
| Walmart | $400+ | $45-$90 | 75-85% |
| CVS | $380-$450 | $50-$110 | 70-80% |
| Costco | $390 | $40-$80 | 80-90% |
Prices fluctuate with location and promotions; generics launched in August 2023 after Takeda lost patent exclusivity, driving immediate drops.[1][3]
When Did Generic Vyvanse Hit the Market?
FDA approved nine generic versions on August 29, 2023, from makers like Teva, Mallinckrodt, and Viatris. They became widely available weeks later, coinciding with ADHD demand spikes. Pre-generic, patients paid full brand price; post-launch, shortages eased but brand still dominates prescriptions (over 60% market share).[3][4]
Why Is There Still a Brand Vyvanse Price Premium?
Takeda holds no active patents blocking generics—key ones expired in 2023 (U.S. Patent No. 7,105,486 for prodrug formulation).[5] Brand pricing reflects marketing, physician loyalty, and insurance formularies favoring originals. Some payers cover generics at zero copay, but brand loyalists or shortages keep Vyvanse viable. No major litigation delays generics further.
What Affects Generic Vyvanse Costs for Patients?
- Insurance/Coupons: With coverage, generics cost $10-$30 copay vs. $50+ for brand. GoodRx or SingleCare cuts cash prices to $30-$60.
- Shortages: Intermittent supply issues (e.g., Teva recalls) push prices up 20-30% temporarily.
- Dosage/Quantity: Higher doses (70 mg) or 90-day supplies save more on generics ($80-$150).
- Alternatives: Cheaper options like generic Adderall XR ($20-$50/month) or amphetamine salts undercut Vyvanse generics for similar ADHD use.[1][2]
Patients switching report seamless efficacy, per user forums and pharmacist data, with no prodrug reformulation differences.[6]
Sources:
[1]: GoodRx Vyvanse Pricing
[2]: Drugs.com Price Guide
[3]: FDA Generic Approvals
[4]: IQVIA Market Data
[5]: DrugPatentWatch Vyvanse Patents
[6]: Reddit/Drugs.com User Reports